Majda Benhayoun, PhD

Tuberculosis Alliance
New York, New York, United States

Disclosure information not submitted.

Presentation(s):

• 547 - An Open-label Multicenter Phase 2 Trial of Telacebec for Adults with Buruli ulcer: the TREAT-BU Trial

  Wednesday, October 22, 2025
  10:42 AM - 10:54 AM US ET